Sydney Health Ethics: Recent submissions
-
Clearing the air: towards agreement about access to high cost cancer medicines
Published 2018-01-01Oncologists have an important role to play in debates about access to high cost cancer medicines. But in order for oncologists to be able to fulfil this role they need to have a solid understanding of the contexts of debates ...Open AccessArticle -
“Treat them into the grave”: cancer physicians’ attitudes towards the use of high cost cancer medicines at the end of life
Published 2018-01-01The prescribing of high cost cancer medicines at the end of life has become a focus of criticism, due primarily to concerns about the safety, efficacy and cost effectiveness of these medicines in this clinical context. In ...Open AccessArticle -
Community views on factors influencing medicines resource allocation: a cross sectional survey of 3080 adults in Australia.
Published 2018-04-01Open AccessArticle -
The use of real world data for the research, development and evaluation of oncology precision medicines
Published 2017-10-01Although randomized controlled trials remain the scientific ideal for determining the efficacy and safety of new treatments, they are sometimes insufficient to address the evidentiary requirements of regulators and payers. ...Open AccessArticle -
An ethical framework for the creation, governance and evaluation of accelerated access programs
Published 2018-09-01There are increasing demands on regulators and insurers internationally to provide access to medicines more quickly, and often on the basis of less robust evidence of safety, efficacy or cost-effectiveness than have ...Open AccessArticle